Zobrazeno 1 - 6
of 6
pro vyhledávání: '"John J. Shelmet"'
Publikováno v:
New England Journal of Medicine. 314:1686-1689
CHEMOTHERAPY of metastatic or otherwise inoperable glucagon-producing islet-cell tumors (glucagonomas) has been unsatisfactory. The agents most frequently used, streptozocin and dacarbazine, are rather toxic and often not very effective.1 Recently a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ae986a62a1c5b7c01136f240701c306
https://doi.org/10.1056/nejm198606263142606
https://doi.org/10.1056/nejm198606263142606
Autor:
R. Shimoyama, John J. Shelmet, G. Boden, I Rezvani, Yoko Fujita-Yamaguchi, Luc Tappy, O E Owen
Publikováno v:
Journal of Clinical Investigation. 81:1971-1978
Sera and their IgG from 10/104 diabetic patients (five with insulin-dependent and five with noninsulin-dependent diabetes, NIDDM), contained antibodies that bound 125I-labeled purified human insulin receptors. 9 of these 10 sera failed to inhibit ins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72230b8822b8da3929c655c4a889f2a9
https://doi.org/10.1172/jci113545
https://doi.org/10.1172/jci113545
Autor:
John J. Shelmet, Robert D. Hoeldtke, Guenther Boden, Oliver E. Owen, Charles L. Skutches, George A. Reichard
Publikováno v:
The Journal of clinical investigation. 81(4)
To study the mechanism of the diabetogenic action of ethanol, ethanol (0.75 g/kg over 30 min) and then glucose (0.5 g/kg over 5 min) were infused intravenously into six normal males. During the 4-h study, 21.8 +/- 2.1 g of ethanol was metabolized and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2c1e579a55b74a35283b0593017856b
https://pubmed.ncbi.nlm.nih.gov/3280601
https://pubmed.ncbi.nlm.nih.gov/3280601
Autor:
Schwartz S; Diabetes and Glandular Disease Research Associates, 5107 Medical Drive, San Antonio, TX 78229, USA. slschwartz@dgdclinic.com, Hassman D, Shelmet J, Sievers R, Weinstein R, Liang J, Lyness W
Publikováno v:
Clinical therapeutics [Clin Ther] 2004 Oct; Vol. 26 (10), pp. 1663-78.
Autor:
Bode B; Atlanta Diabetes Associates, Georgia, Shelmet J; Lawrenceville, New Jersey, Gooch B; Melbourne Internal Medicine Associates, Melbourne, Florida, Hassman DR; Comprehensive Clinical Research, Berlin, New Jersey, Liang J; Novo Nordisk Pharmaceuticals, Princeton, New Jersey, Smedegaard JK; Novo Nordisk A/S, Sorgenfri, Denmark, Skovlund S; Novo Nordisk A/S, Sorgenfri, Denmark, Berg B; Novo Nordisk A/S, Sorgenfri, Denmark, Lyness W; Novo Nordisk Pharmaceuticals, Princeton, New Jersey, Schneider SH; Division of Endocrinology, Metabolism, and Nutrition, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey
Publikováno v:
The Diabetes educator [Diabetes Educ] 2004 Mar-Apr; Vol. 30 (2), pp. 301-9.
Autor:
Shelmet J; Diabetes & Glandular Disease Clinic, 5107 Medical Drive, San Antonio, TX 78229, USA. jjsdiabetes@aol.com, Schwartz S, Cappleman J, Peterson G, Skovlund S, Lytzen L, Nicklasson L, Liang J, Lyness W
Publikováno v:
Diabetes research and clinical practice [Diabetes Res Clin Pract] 2004 Jan; Vol. 63 (1), pp. 27-35.